What Does Institutional Ownership Look Like At AbbVie Inc. (ABBV)?

About 2.39 million shares traded. It has underperformed by 72.81% the S&P500. (NYSE:ABBV). Pitcairn Com stated it has 0.16% of its portfolio in AbbVie Inc.

The chart of AbbVie Inc. Eventide Asset holds 2.52% in AbbVie Inc.

More notable recent AbbVie Inc. The total number of shares traded in the last 12 months is 1.83 million. Skandinaviska Enskilda Banken AB publ now owns 1,202,483 shares of the company's stock valued at $78,354,000 after purchasing an additional 357,353 shares during the period.

AbbVie (NYSE:ABBV) last issued its quarterly earnings data on Friday, October 27th. A 11 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of ABBV or, if they already own its stock, sell it. Therefore 100% are positive. $99.85 was the targeted price for AbbVie Inc. having a 5,114,214 volume of shares. The rating was maintained by Jefferies on Monday, June 26 with "Buy". The rating was initiated by Societe Generale on Wednesday, April 6 with "Sell". SunTrust maintained the shares of ABBV in report on Sunday, October 29 with "Buy" rating. The company was upgraded on Monday, September 28 by Citigroup. The firm has "Hold" rating by Deutsche Bank given on Monday, July 17. The company was maintained on Friday, March 10 by Goldman Sachs. More interesting news about AbbVie Inc. They issued an "outperform" rating and a $95.00 price objective on the stock. BMO Capital Markets has "Hold" rating and $6600 target. (NYSE:ABBV) on Thursday, May 25 with "Buy" rating.

Walleye Trading Llc decreased its stake in Abbvie Inc (Put) (ABBV) by 43.36% based on its latest 2017Q2 regulatory filing with the SEC. On Friday, October 27 the stock rating was maintained by Barclays Capital with "Equal-Weight". Its up 0.01, from 0.99 in 2017Q1.

At the session level, shares of AbbVie Inc.(NYSE:ABBV) moved -1.36% from the open.

14 analysts on average are expecting the company to report revenue of $7.5 Billion for the current quarter. (NYSE:ABBV). Clinton Group owns 0.41% invested in AbbVie Inc. (NYSE:ABBV) by 6.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission.

The top 5 institutional holders, in ascending order, are as follows: CAPITAL RESEARCH GLOBAL INVESTORS with 189.02 million shares, VANGUARD GROUP INC with 117.95 million shares, BLACKROCK INC. with 98.61 million shares, STATE STREET CORP with 68.25 million shares, and NORTHERN TRUST CORP with 22.32 million shares. (NYSE:ABBV). Hodges Capital Mngmt holds 0.22% of its portfolio in AbbVie Inc. Pura Vida Invs Limited Liability Corp has invested 1.32% in AbbVie Inc. Mercer Capital Advisers Inc. owns 27,873 shares or 0.83% of their United States portfolio. First Dallas Incorporated invested in 32,282 shares. Jpmorgan Chase Com reported 0.06% of its portfolio in AbbVie Inc. The firm owned 189,015,179 shares of the company's stock after buying an additional 10,740,344 shares during the period. Evercore ISI started coverage on shares of AbbVie in a report on Wednesday, August 16th. Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 0.00 as current ratio and on the opponent side the debt to equity ratio was 0.37 and long-term debt to equity ratio also remained 0.32. The shares of the corporation went down by -9.24% during the previous month.

Now we will discuss the financial strength of AbbVie Inc. Spdr Dow Jones Indl Avrg Etf U (DIA) was raised too.

Since June 14, 2017, it had 0 insider purchases, and 2 selling transactions for $8.79 million activity. There were 65 sold out positions, amounting to 3.33 million shares. Insiders sold a total of 277,125 shares of company stock worth $25,891,756 over the last three months. (NYSE:ABBV) or 45,800 shares. The Return on Equity ratio of AbbVie Inc. The company reported $1.41 EPS for the quarter, topping the Zacks' consensus estimate of $1.39 by $0.02. ABBV's profit will be $2.28 billion for 16.51 P/E if the $1.43 EPS becomes a reality. Community Bank N.A. grew its stake in shares of AbbVie by 1.6% during the 1st quarter.

Fulton Bank increased Dodge & Cox Fds (DODFX) stake by 380,726 shares to 672,146 valued at $29.33M in 2017Q2.

The company's Average Earnings Estimate for the Current Fiscal quarter is $1.44, according to consensus of 16 analysts.

Analysts look for public financial statements, listen in on conference calls and talk to managers and customers of a company in order to reach an opinion and communicate the value of a stock. Cordasco Networks reported 0.16% stake.

The SMA20 for the stock is at 0.52 percent, SMA50 stands at 3.08 percent, while SMA200 is 26.43 Percent. The stock decreased 3.22% or $0.44 during the last trading session, reaching $13.38. Hanson & Doremus Inv, Vermont-based fund reported 5,609 shares. Pinnacle Assocs Ltd, a New York-based fund reported 81,512 shares. That's a potential 1.76 gain from where (NASDAQ:QCOM) has been trading recently. Therefore 42% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has "Hold" rating by Deutsche Bank on Thursday, July 20. Orchids Paper Products Company (NYSEMKT:TIS) has declined 56.11% since December 6, 2016 and is downtrending. The stock has "Buy" rating by Piper Jaffray on Friday, September 15.